Gilead Sciences Inc (GILD)
84.59
+0.42
(+0.50%)
USD |
NASDAQ |
Oct 04, 16:00
84.59
0.00 (0.00%)
Pre-Market: 20:00
Gilead Sciences Shareholders Equity (Annual): 22.83B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 22.83B |
December 31, 2022 | 21.24B |
December 31, 2021 | 21.07B |
December 31, 2020 | 18.20B |
December 31, 2019 | 22.52B |
December 31, 2018 | 21.39B |
December 31, 2017 | 20.44B |
December 31, 2016 | 18.89B |
December 31, 2015 | 18.53B |
December 31, 2014 | 15.43B |
December 31, 2013 | 11.37B |
December 31, 2012 | 9.303B |
December 31, 2011 | 6.739B |
December 31, 2010 | 5.864B |
December 31, 2009 | 6.367B |
December 31, 2008 | 4.273B |
December 31, 2007 | 3.460B |
Date | Value |
---|---|
December 31, 2006 | 1.816B |
December 31, 2005 | 3.028B |
December 31, 2004 | 1.871B |
December 31, 2003 | 1.003B |
December 31, 2002 | 571.34M |
December 31, 2001 | 452.44M |
December 31, 2000 | 351.12M |
December 31, 1999 | 297.29M |
December 31, 1998 | 333.70M |
December 31, 1997 | 317.30M |
December 31, 1996 | 291.70M |
December 31, 1995 | 151.50M |
March 31, 1995 | 86.10M |
March 31, 1994 | 115.30M |
March 31, 1993 | 139.40M |
March 31, 1992 | 105.60M |
March 31, 1991 | 10.20M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
18.20B
Minimum
2020
22.83B
Maximum
2023
21.17B
Average
21.24B
Median
2022
Shareholders Equity (Annual) Benchmarks
Amgen Inc | 6.232B |
Pfizer Inc | 89.01B |
Eli Lilly and Co | 10.77B |
Merck & Co Inc | 37.58B |
Johnson & Johnson | 68.77B |